Article
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).
European journal of cancer (Oxford, England : 1990) - 1 Jun 2010
Correale Pierpaolo, Marra Monica, Remondo Cinzia, Migali Cristina, Misso Gabriella, Arcuri Felice Paolo, Del Vecchio Maria Teresa, Carducci Antonietta, Loiacono Lucia, Tassone Pierfrancesco, Abbruzzese Alberto, Tagliaferri Pierosandro, Caraglia Michele
Abstract excerpt
Cetuximab is a human-murine chimeric IgG1 monoclonal antibody to epidermal growth factor-receptor (EGFR) which exerts synergistic antitumour interactions with several cytotoxic drugs. Therefore, it is presently recommended in combination with chemotherapy in the treatment of colon, head and neck and non-small cell lung cancer. Cetuximab has been designed to inhibit EGFR signalling; however, preclinical evidence...
Topics
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antibody-Dependent Cell Cytotoxicity
- Antineoplastic Agents
- Blotting, Western
- Camptothecin
- Cell Line, Tumor
- Cetuximab
